AstraZeneca smashes forecasts in second quarter after seeing off Pfizer
- Written by Editor
- Published in News Feeds
LONDON (Reuters) - AstraZeneca smashed forecasts for second-quarter sales and earnings on Thursday, demonstrating resilience after seeing off a $118 billion takeover approach from rival drugmaker Pfizer two months ago.